C12Y 106/03001
Nadh oxidase , i.e. nox1
Official title: NAD(P)H oxidase (1.6.3.1), i.e. NOX1
C12Y106/03001 (Nadh oxidase , i.e. nox1) appears on 29 US grants and 61 published applications in this corpus.
Search patents in C12Y- Granted patents
- 29
- Published applications
- 61
- Assignees
- 42
- Inventors
- 135
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 2 | 4 |
| 2017 | 1 | 6 |
| 2018 | 1 | 2 |
| 2019 | 3 | 5 |
| 2020 | 3 | 4 |
| 2021 | 4 | 7 |
| 2022 | 3 | 7 |
| 2023 | 2 | 3 |
| 2024 | 6 | 8 |
| 2025 | 1 | 4 |
| 2026 | 2 | 7 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Heterologous proteins with axonemal proteins7 Jul 2026US 12,673,977 B2The Regents of the University of California
- Compositions and methods for treating amyotrophic lateral sclerosis2 Jun 2026US 12,644,122 B2Children's Medical Center Corporation
- Recombinant host cells and methods for the production of glyceric acid and downstream products7 Jan 2025US 12,188,008 B2Lygos, Inc.
- Plant cells and plants modified to increase resistance to necrotrophs or drought and methods of selecting and using the same10 Dec 2024US 12,163,143 B2Wisconsin Alumni Research Foundation
- Methods for decoupling yield and productivity of a non-catabolic compound produced by a host cell24 Sep 2024US 12,098,407 B2Amyris, Inc.
- Plants comprising bromoform production genes8 Oct 2026US 2026/0308605 A1Imi Tami Institute for Research and Development Ltd.
- Method for producing d-talitol, d-tagatose, and d-psicose8 Oct 2026US 2026/0308649 A1Annikki GmbH
- Oxidase-based chemiluminescence assay of phagocytic leukocytes in whole blood and body fluids applicable to point-of-care (poc) diagnostic testing point-of-care (poc) measurement of absolute neutrophil function (anf)27 Aug 2026US 2026/0251635 A1Binary, LLC
- Compositions, devices and methods for the control in vitro of chemical microambient in cell cultures6 Aug 2026US 2026/0226408 A1Alma Mater Studiorum - Università di Bologna
- Oxidase-based chemiluminescence assay of phagocytic leukocytes in whole blood and body fluids applicable to point-of-care (poc) diagnostic testing point-of-care (poc) measurement of absolute neutrophil function (anf)14 May 2026US 2026/0133184 A1Binary, LLC
Most cited
By later US patents
- Diagnosis and therapy of multiple sclerosis2US 10,633,427 B2Prindex S.R.L. · 2020
- Compositions for treatment of vascular disease2US 11,091,524 B1Houston Gene Therapeutics LLC · 2021
- Nucleic acid aptamers2US 9,139,835 B2University of Iowa Research Foundation · 2015
- Plant cells and plants modified to increase resistance to necrotrophs or drought and methods of selecting and using the same1US 11,136,591 B2Wisconsin Alumni Research Foundation · 2021
- Compositions for treatment of vascular disease1US 11,274,134 B2Houston Gene Therapeutics LLC · 2022